GI Tolerability Differences Some patients experience persistent nausea on semaglutide but find tirzepatide easier to tolerate at equivalent dose stages, or vice versa
Patients with gastroparesis, history of pancreatitis, renal impairment, or severe dehydration require careful evaluation
Most available trials to date are small and short-term, without proper blinding of participants or researchers, so theyll need much larger placebo-controlled trials in people with eating disorders before they know the drugs actual effectiveness and long-term safety
For urgent concerns, contact NHS 111 for advice
A little birdie whispered that we can expect Vlado Perkovic to take the stage at the 61st European Renal Association Congress in Stockholm, Sweden, in late May
Just know this has not yet been evaluated in clinical trials